Physical- and Chemical-Dually ROS-Responsive Nano-in-Gel Platforms with Sequential Release of OX40 Agonist and PD-1 Inhibitor for Augmented Combination Immunotherapy-Reference-Cited by-同舟云学术

Physical- and Chemical-Dually ROS-Responsive Nano-in-Gel Platforms with Sequential Release of OX40 Agonist and PD-1 Inhibitor for Augmented Combination Immunotherapy

Published:2023-02-13 Issue:4 Volume:23 Page:1424-1434
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Fu Yu¹,Huang Yulan¹,Li Pingrong¹,Wang Luyao²,Tang Zhongjie¹,Liu Xinlong¹,Bian Xufei¹,Wu Shuang¹,Wang Xiaoyou¹,Zhu Biyue³,Yu Yang¹,Jiang Jiayun⁴,Li Chong¹^ORCID

Affiliation:

1. Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China

2. Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford OX1 2JD, U.K.

3. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Harvard University, Charlestown, Massachusetts 02138, United States

4. Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University/Army Medical University, Chongqing 400038, P.R. China

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Natural Science Foundation of Chongqing, China

Doctoral Through Train Scientific Research Project of Chongqing

Sichuan Science and Technology Program

Innovative Research Group at Higher Educational Institutions in Chongqing

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.2c04767

Reference45 articles.

1. A decade of immune-checkpoint inhibitors in cancer therapy

2. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

3. Novel Cocktail Therapy Based on a Nanocarrier with an Efficient Transcytosis Property Reverses the Dynamically Deteriorating Tumor Microenvironment for Enhanced Immunotherapy

4. Game-changing class of immunotherapy drugs lengthens melanoma survival rates

5. New survival standards for advanced melanoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy;Nano Letters;2024-05-21

2. Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages;Nano Letters;2024-01-25

3. Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer;Advanced Drug Delivery Reviews;2023-11

4. Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy;Journal of Nanobiotechnology;2023-07-04